Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown CytomX Therapeutics Inc. CTMX

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company which is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platform. The company probody technology platform to create proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of unique conditions in the tumor microenvironment to enhance the tumor-targeting...


Top institutional share ownership of CytomX Therapeutics Inc

Name Shares Shares % change Value Value % change
Bvf Inc/il 5,803,700 0.0% $15,496 -38.3%
Rtw Investments, Lp 5,779,700 -4.2% $15,432 -40.9%
Vanguard Group Inc 5,078,387 -2.8% $9,294 -33.4%
Point72 Asset Management, L.P. 4,371,300 -30.7% $11,671 -57.2%
Rubric Capital Management LP 2,406,449 0.0% $6,425 0.0%
Millennium Management Llc 2,245,190 77.2% $5,995 9.3%
Orbimed Advisors Llc 2,124,975 -33.9% $5,674 -59.2%
Adage Capital Partners Gp, L.l.c. 2,000,000 $5,340
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 1,946,133 6.6% $5,196 -34.3%
Acadian Asset Management Llc 1,839,226 107.8% $3,366 42.5%

Top institutional buyers of CytomX Therapeutics Inc

Name Shares % change Value % change Shares Value
Acadian Asset Management Llc 107.8% 42.5% 1,839,226 $3,366
Pictet Asset Management Sa 87.1% 28.2% 660,495 $1,209
Millennium Management Llc 77.2% 9.3% 2,245,190 $5,995
Renaissance Technologies Llc 62.3% 11.3% 1,454,261 $2,661
Platinum Investment Management Ltd 25.5% -14.0% 1,229,545 $2,250
Goldman Sachs Group Inc 19.1% -26.5% 758,589 $2,026
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 6.6% -34.3% 1,946,133 $5,196
Fmr Llc 0.2% -31.3% 703,209 $1,287
Price T Rowe Associates Inc /md/ 0.2% -38.2% 661,063 $1,765

Top institutional sellers of CytomX Therapeutics Inc

Name Shares % change Value % change Shares Value
BlackRock Inc. -63.4% -74.9% 1,826,591 $3,343
State Street Corp -56.3% -73.0% 1,198,682 $3,200
XBI - SPDR(R) S&P(R) Biotech ETF -42.9% -51.5% 1,588,262 $6,877
Orbimed Advisors Llc -33.9% -59.2% 2,124,975 $5,674
Point72 Asset Management, L.P. -30.7% -57.2% 4,371,300 $11,671
Jacobs Levy Equity Management, Inc -13.2% -46.5% 1,075,110 $2,871
Rtw Investments, Lp -4.2% -40.9% 5,779,700 $15,432
Vanguard Group Inc -2.8% -33.4% 5,078,387 $9,294
IWM - iShares Russell 2000 ETF -2.5% -39.9% 1,487,388 $3,971
VEXMX - Vanguard Extended Market Index Fund Investor Shares -0.4% -38.6% 843,775 $2,253

Information provided by Fintel.io